Mubadala Health Dubai is part of M42, a global tech-enabled healthcare company that combines world-class medical expertise with advanced technology solutions. M42 was created through the coming together of Mubadala Health and G42 Healthcare, setting a new standard for innovation-driven, patient-centric care.
M42 operates, manages, and develops a portfolio of leading healthcare assets, including Cleveland Clinic Abu Dhabi, Healthpoint, Imperial College London Diabetes Centre (ICLDC), Amana Healthcare, National Reference Laboratory (NRL), Capital Health Screening Centre (CHSC), Abu Dhabi Telemedicine Centre (ADTC), Danat Al Emarat, HealthPlus Diabetes & Endocrinology Centre, HealthPlus Family Clinics, HealthPlus Fertility, HealthPlus Women’s Health Center, and Moorfields Eye Hospital Abu Dhabi.
With a vision to transform the regional healthcare landscape, M42 pioneers integrated healthcare solutions, combining clinical excellence with cutting-edge technology to improve patient outcomes. Innovation, research, and education remain core pillars, ensuring a sustainable and future-ready healthcare ecosystem in alignment with Abu Dhabi’s and the region’s healthcare vision.
As an extension of our decades of healthcare excellence in the UAE, Mubadala Health Dubai, located in Jumeirah, provides patients with convenient access to a wide range of medical and surgical specialties for both adults and children. Delivered by world-class caregivers and aligned with international care standards, the facility also includes a satellite clinic for Imperial College London Diabetes Centre and Cleveland Clinic Abu Dhabi, ensuring seamless and specialized care.